- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02376842
Study of an Electronic Health Record-embedded Severe Sepsis Early Warning Alert
Single-blind Randomized Trial of a Commercially Sold Electronic Health Record Based Severe Sepsis Early Warning Best Practice Alert.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sepsis is the leading cause of mortality at Stanford Hospital and ranks only 54th out of 119 hospitals according to UHC data with approximately 60 episodes of documented sepsis per quarter. Based on some preliminary data, there is concern that sepsis is both being recognized late and not treated in a timely enough fashion. In fact, there are evidence and expert guidelines that suggestion-delaying antibiotics in a patient with septic shock can increase mortality by 6.7% per hour (1C recommendation in severe sepsis by the Surviving Sepsis Campaign authors). As part of a hospital wide initiative to improve our treatment of sepsis and ultimately reduce sepsis-related mortality, an EHR-based clinical decision support (aka BPA) will be implemented. This BPA will be an algorithm that will alert practitioners and trigger clinical workflow after criteria are met. Criteria include lab values, vital signs and nursing flow sheet descriptions of perfusion (Table 1). The algorithm will alert when, in a 24 hour period, three criteria from the manifestation group, one criteria from the suspected infection group and one criteria from the organ dysfunction group. Note that one variable (eg creatinine > 2) can fulfill criteria in more than one group. Figure 1 contains details of proposed EHR workflow. After criteria are met, whomever is next in the chart with RN or MD user-type, will receive an interruptive alert via the EHR; simultaneously a page will automatically be sent by the EHR to a crisis nurse who will assess the patient and notify the primary MD and RN.
Electronic early warning systems and predictive analytic tools lack rigorous evaluation and standardization. There are literature demonstrating unintended consequences and even harms from the implementation of electronic health records and clinical decision support tools. As such, this is a situation of clinical equipoise in which it is unclear whether this quality improvement initiative will benefit patient care or not. To evaluate this question, the severe sepsis BPA will be initiated in a randomized fashion with each patient randomly assigned to either potentially generate this alert as described above or to generate this alert silently such that only quality improvement staff will be aware that criteria have been met via the EHR.
This is a randomized, single-blind prospective quality improvement study. Patients will be randomized by encounter to have the BPA visible or invisible during hospital admission. If visible, the alert will display to the primary nurse and physician and send a page to a crisis nurse when BPA criteria are met. If invisible, the alert will be triggered but will be invisible to the care team (only visible to quality improvement staff via the EHR)
Inclusion criteria
o Admitted to Stanford Hospital (inpatient or observation status) to any medical or surgical service for at least 24 hours during the period of the study
Exclusion criteria
o Admitted to an intensive-care level service (MICU, SICU, CVICU, CCU)
While ideally we will make this available to ICU patients, the alert is likely to be far less specific in ICU patients and less clinically useful given the high level of care (eg 1:1 nursing and hourly vital signs).
o Patient code status is DNR/C (comfort care only)
These patients would not be appropriate to treat with antibiotics and aggressive care generally give the comfort care goals of care.
o Emergency Department patients (may be included in the near future)
Primary endpoints
o Percentage of patients receiving antibiotics within three hours
Secondary endpoints
- Percentage of patients with hypotension or lactate >= 4 who received at least 30 ml/kg fluid
- Rate of 3 hour sepsis bundle completion (serum lactate, blood cultures, antibiotics)
- Length of hospital stay
- Cost of hospital stay per day and overall cost
- Mortality at hospital discharge
Sample size and duration
- Based on prior studies, we predict a 10-15% difference in one or more primary endpoints (see Sawyer et. Al, Crit Care Med. 2011 March, 39:469)
- We therefore anticipate enrolling 1500 patients, an estimated 150 of whom will have true sepsis, over approximately six months, to achieve 80% power.
- Analysis will compare endpoints among all patients in the treatment and control groups
- Early stopping will be decided by an oversight committee which will review data at 3 months. If there is statistically significant different of more than 10% between groups, the study will be terminated early and in discussion with hospital quality and safety committee, use whichever strategy is superior for all patients in the hospital.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admitted to Stanford Hospital (inpatient or observation status) to any medical or surgical service for at least 24 hours during the period of the study
Exclusion Criteria:
- Admitted to an intensive-care level service (MICU, SICU, CVICU, CCU)
- Patient code status is DNR/C (comfort care only)
- Patients less than 18 years of age at time of admission.
- Emergency Department patients (may be included in the near future)
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Severe sepsis early warning best practice alert
Patients in this arm will actively generate the alert.
|
|
|
Placebo Comparator: Standard care
This arm will be the current standard of care and will not generate the alert.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of patients with an antibiotic order within 3 hours of the alert
Time Frame: 3 hours
|
Time from when the alert fires until appropriate antibiotics are ordered will be measured via the electronic health record and a sample of cases will be verified by manual chart review.
|
3 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Westphal GA, Koenig A, Caldeira Filho M, Feijo J, de Oliveira LT, Nunes F, Fujiwara K, Martins SF, Roman Goncalves AR. Reduced mortality after the implementation of a protocol for the early detection of severe sepsis. J Crit Care. 2011 Feb;26(1):76-81. doi: 10.1016/j.jcrc.2010.08.001. Epub 2010 Oct 30.
- Nelson JL, Smith BL, Jared JD, Younger JG. Prospective trial of real-time electronic surveillance to expedite early care of severe sepsis. Ann Emerg Med. 2011 May;57(5):500-4. doi: 10.1016/j.annemergmed.2010.12.008. Epub 2011 Jan 12.
- Brandt BN, Gartner AB, Moncure M, Cannon CM, Carlton E, Cleek C, Wittkopp C, Simpson SQ. Identifying severe sepsis via electronic surveillance. Am J Med Qual. 2015 Nov-Dec;30(6):559-65. doi: 10.1177/1062860614541291. Epub 2014 Jun 26.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3675309
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Sepsis
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Rennes University HospitalUnknownSevere Sepsis or Septic Shock
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Severe InfectionFrance, Spain
-
Centre Hospitalier Universitaire de NiceUnknownComparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis. (PREDI)Severe Sepsis and Septic ShockFrance
-
Yonsei UniversityCompletedSevere Sepsis or Septic ShockKorea, Republic of
-
University of RostockCompletedSevere Sepsis and Septic ShockGermany
-
Klinikum EmdenUniversitätsklinikum Hamburg-Eppendorf; Kantonsspital Baden; Kantonsspital MünsterlingenCompleted
-
University Hospital, Strasbourg, FranceUnknownSevere Sepsis and Septic ShockFrance
-
Peking Union Medical College HospitalUnknownLactate | Severe Sepsis With Septic Shock
Clinical Trials on Standard care
-
University of LahoreRecruitingDiabetic Foot UlcerPakistan
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
The General Hospital of Western Theater CommandRecruitingMucositis | Hematopoietic Stem Cell Transplantation | Radiation-Induced Mucositis | Chemotherapy-Induced MucositisChina
-
brett rasmussenCompleted
-
Queen Mary University of LondonCompleted
-
University of Missouri-ColumbiaCompletedLow Back Pain | Pelvic Pain | Adhesions | Scar TissueUnited States